1. Home
  2. ILMN vs VTR Comparison

ILMN vs VTR Comparison

Compare ILMN & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • VTR
  • Stock Information
  • Founded
  • ILMN 1998
  • VTR 1983
  • Country
  • ILMN United States
  • VTR United States
  • Employees
  • ILMN N/A
  • VTR N/A
  • Industry
  • ILMN Medical Specialities
  • VTR Real Estate Investment Trusts
  • Sector
  • ILMN Health Care
  • VTR Real Estate
  • Exchange
  • ILMN Nasdaq
  • VTR Nasdaq
  • Market Cap
  • ILMN 22.9B
  • VTR 27.3B
  • IPO Year
  • ILMN 2000
  • VTR 1998
  • Fundamental
  • Price
  • ILMN $141.09
  • VTR $61.65
  • Analyst Decision
  • ILMN Buy
  • VTR Buy
  • Analyst Count
  • ILMN 20
  • VTR 10
  • Target Price
  • ILMN $160.68
  • VTR $61.60
  • AVG Volume (30 Days)
  • ILMN 2.1M
  • VTR 2.5M
  • Earning Date
  • ILMN 11-04-2024
  • VTR 10-30-2024
  • Dividend Yield
  • ILMN N/A
  • VTR 2.92%
  • EPS Growth
  • ILMN N/A
  • VTR N/A
  • EPS
  • ILMN N/A
  • VTR N/A
  • Revenue
  • ILMN $4,390,000,000.00
  • VTR $4,797,115,000.00
  • Revenue This Year
  • ILMN N/A
  • VTR N/A
  • Revenue Next Year
  • ILMN $4.28
  • VTR $7.07
  • P/E Ratio
  • ILMN N/A
  • VTR N/A
  • Revenue Growth
  • ILMN N/A
  • VTR 10.05
  • 52 Week Low
  • ILMN $97.36
  • VTR $41.45
  • 52 Week High
  • ILMN $156.66
  • VTR $67.61
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 48.42
  • VTR 37.06
  • Support Level
  • ILMN $138.88
  • VTR $61.73
  • Resistance Level
  • ILMN $144.00
  • VTR $65.24
  • Average True Range (ATR)
  • ILMN 4.58
  • VTR 0.98
  • MACD
  • ILMN -0.05
  • VTR -0.26
  • Stochastic Oscillator
  • ILMN 69.62
  • VTR 7.35

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About VTR Ventas Inc.

Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Share on Social Networks: